Convergence Investment Partners’s AMAG Pharmaceuticals AMAG Stock Holding History

Convergence Investment Partners’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-18,412	Closed	-$280K	–	391
2018 Q4	$280K	Buy	+18,412	New	+$351K	0.06%	261
2017 Q2	–	Sell	-50,182	Closed	-$1.13M	–	421
2017 Q1	$1.13M	Buy	50,182 +17,412	+53%	+$417K	0.16%	231
2016 Q4	$1.14M	Buy	+32,770	New	+$979K	0.16%	250
2015 Q4	–	Sell	-28,356	Closed	-$1.13M	–	409
2015 Q3	$1.13M	Buy	+28,356	New	+$1.76M	0.13%	242
2015 Q1	–	Sell	-16,492	Closed	-$703K	–	434
2014 Q4	$703K	Buy	+16,492	New	+$596K	0.09%	292

Other funds holding AMAG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Convergence Investment Partners's AMAG Position: Q1 2019 in Review

Convergence Investment Partners sold out of AMAG Pharmaceuticals (AMAG) in Q1 2019, closing a stake of 18,412 shares — an estimated $280K sold.

Convergence Investment Partners first reported a position in AMAG in Q4 2014 and held it in 5 quarters. The position peaked at $1.14M in Q4 2016. 166 funds tracked by Wall St. Rank hold AMAG as of Q1 2019.

Convergence Investment Partners reported no remaining AMAG Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
Convergence Investment Partners sold 18,412 AMAG Pharmaceuticals shares in Q1 2019, an estimated $280K.
Convergence Investment Partners first reported a position in AMAG Pharmaceuticals in Q4 2014 and held it in 5 quarters.
Convergence Investment Partners's AMAG Pharmaceuticals position peaked at $1.14M in Q4 2016.
166 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2019.

Based on Convergence Investment Partners's 13F filing for Q1 2019, filed 1 May 2019.